Trump’s generic drug tariff bomb: Why it’s not good news for India’s pharma giants
US President Donald Trump has announced a phased tariff plan on imported generic medicines that could bring major changes to the international pharmaceutical supply chain and create new hurdles for India, the world’s largest supplier of generic drugs to the United States. Under the new policy, the medicines imported into the United States will continue…
